MedPath

SPECTRO ACNECARE SPOT TREATMENT

SPECTRO ACNECARE SPOT TREATMENT

Discontinued
DIN Number

02428814

Drug Class

Human

Market Date

N/A

Company
HC

glaxosmithkline consumer healthcare ulc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02428814
AIG Number0107205005
Classification & Schedule
C
Drug Class
Human
S
Schedule
OTC
A
ATC Code
D10AE01 BENZOYL PEROXIDE
Product Specifications
Dosage FormGel
Route of AdministrationTopical
AHFS Classification84:28.00
Health Canada Classification

ACTIVE INGREDIENTS (1)

BENZOYL PEROXIDEActive
Strength: 3 % / W/W
Monograph: BENZOYL PEROXIDE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.